Post by Molecular Devices

In a recent piece by News Medical, Boyd Butler, Global Product Marketing Manager for Imaging at Molecular Devices, explores how advances in AI, 3D imaging, and automation are transforming phenotypic discovery: https://hubs.la/Q04nPy8z0. From enabling more physiologically relevant 3D models to improving the quality and scalability of imaging workflows, Butler highlights a critical shift: success in AI-driven analysis starts with the data itself. High-quality, AI-ready image data—combined with robust optics and automation—allows researchers to extract deeper insights and make more confident decisions. As drug discovery becomes increasingly complex, this convergence of technologies is helping scientists detect subtle biological changes, improve reproducibility, and accelerate time to insight. Read the full article: https://hubs.la/Q04nPy8z0. #HighContentScreening #HighContentImaging #ImageAnalysis #3DBiology #3DModels #DrugDiscovery #AIDrivenGrowth #Automation #DanaherNews